Symbio’s Flagship R&D Centre
Symbio has a fully equipped, state-of-the-art R&D Centre in Jigani (Bengaluru) with highly experienced & skilled industry professionals.Driving Innovation and Collaboration in Pharmaceutical Science
Symbio’s state-of-the-art R&D Centre in Bangalore’s pharmaceutical research hub (Jigani) is the nucleus of our scientific ambition - where chemistry, curiosity, and collaboration converge. Purpose-built to fuel our API and CDMO innovation engine, the centre embodies our commitment to process excellence, green chemistry, and scalable innovation that meets the evolving demands of global healthcare.
Advanced Infrastructure for Complex and Sustainable Chemistry
Spread across 1+ acre, the R&D facility can house up to 100 fume hoods, dedicated areas for potent molecule development, and a specialized peptide research wing. It is designed to translate lab-scale ideas into commercially viable processes through deep process optimization, enzymatic synthesis, and continuous improvement methodologies. This integrated infrastructure bridges discovery and delivery, serving both Symbio’s internal API pipeline and external CDMO partnerships.
A Strategic Hub for Innovation and Global Partnerships
More than merely a “R&D” centre, we consider it as Symbio’s innovation nerve centre - where new molecules take shape, and new collaborations are born. Staffed by seasoned scientists with decades of experience in API process development, CRAMS, and technology transfer, it enables us to deliver efficient, compliant, and sustainable manufacturing solutions for partners worldwide. From bench to commercial scale, Symbio’s R&D ecosystem powers transformation – one molecule at a time.
